107902-68-1Relevant academic research and scientific papers
Regiospecific reduction of 5-benzylidene-2,4-thiazolidinediones and 4- oxo-2-thiazolidinethiones using lithium borohydride in pyridine and tetrahydrofuran
Giles, Robert G.,Lewis, Norman J.,Quick, John K.,Sasse, Michael J.,Urquhart, Michael W. J.,Youssef, Latifa
, p. 4531 - 4537 (2007/10/03)
The novel regiospecific and general reduction of 5-benzylidene-2,4- thiazolidinediones and 5-benzylidene-4-oxo-2-thiazolidinethiones to the corresponding 5-benzyl derivatives has been accomplished using lithium borohydride in pyridine and tetrahydrofuran. Sodium borohydride and lithium chloride can also be used under these conditions, which represents a cheaper alternative to lithium borohydride. (C) 2000 Elsevier Science Ltd.
Method for treating multiple sclerosis
-
, (2008/06/13)
Provided is a method of treating multiple sclerosis employing certain aryl-substituted rhodanines.
Synthesis of enantioenriched 4-thiazolidinone (-)-LY213829 by chemoselective benzylamide cleavage in the presence of a C-S bond
Hansen, Marvin M.,Harkness, Allen R.,Khau, Vien V.,Martinelli, Michael J.,Deeter, Jack B.
, p. 2515 - 2518 (2007/10/03)
(R)-2-Methylbenzylamine has been used to covalently 'resolve' thiol acid 7 and assemble 4-thiazolidinone 8a in one step. Selective deprotection of the 2-methylbenzylamide using lithium in ammonia/THF has been achieved in the presence of a readily hydrogen
Aryl-substituted rhodanine derivatives
-
, (2008/06/13)
Provided are certain aryl-substituted rhodanine derivatives, treatment methods and pharmaceutical formulations thereof.
Method of treating inflammatory bowel disease
-
, (2008/06/13)
Provided is a method of treating inflammatory bowel disease in mammals utilizing certain benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted rhodanine derivatives and pharmaceutical compositions thereof, as well as a novel process for selectively isolating in substantially pure enantiomeric form the enantiomers of certain racemic benzyl-substituted rhodanine derivatives.
Method of treating type I diabetes
-
, (2008/06/13)
Provided is a method for treating Type I diabetes in mammals utilizing certain aryl-substituted rhodanine derivatives.
